Total Payments
$1,748
2023 Payments
$149.12
Companies
6
Transactions
21
Medicare Patients
3,273
Medicare Billing
$288,979
Payment Breakdown by Category
Food & Beverage$1,736 (99.4%)
Education$11.22 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,736 | 20 | 99.4% |
| Education | $11.22 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $739.04 | 11 | $0 (2022) |
| Horizon Pharma plc | $506.99 | 5 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $204.38 | 2 | $0 (2019) |
| Boston Scientific Corporation | $149.12 | 1 | $0 (2023) |
| Amgen Inc. | $125.00 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $23.05 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $149.12 | 1 | Boston Scientific Corporation ($149.12) |
| 2022 | $120.55 | 2 | Horizon Therapeutics plc ($120.55) |
| 2021 | $401.92 | 5 | Horizon Therapeutics plc ($276.92) |
| 2019 | $444.76 | 6 | Horizon Therapeutics plc ($341.57) |
| 2018 | $492.75 | 5 | Horizon Pharma plc ($391.56) |
| 2017 | $138.48 | 2 | Horizon Pharma plc ($115.43) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2023 | Boston Scientific Corporation | APOLLO ESG System (Device) | Food and Beverage | In-kind items and services | $149.12 | General |
| Category: APOLLO ESG System_ENDO | ||||||
| 04/20/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $109.33 | General |
| Category: KRYSTEXXA | ||||||
| 03/17/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Education | In-kind items and services | $11.22 | General |
| Category: KRYSTEXXA | ||||||
| 11/01/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: KRYSTEXXA | ||||||
| 09/29/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 09/21/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $125.79 | General |
| Category: KRYSTEXXA | ||||||
| 09/21/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: KRYSTEXXA | ||||||
| 04/01/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $128.50 | General |
| Category: KRYSTEXXA | ||||||
| 08/18/2019 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: RAYOS | ||||||
| 08/01/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $149.11 | General |
| Category: KRYSTEXXA | ||||||
| 08/01/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: KRYSTEXXA | ||||||
| 02/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $103.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/29/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $118.77 | General |
| Category: KRYSTEXXA | ||||||
| 01/29/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $37.32 | General |
| Category: KRYSTEXXA | ||||||
| 06/19/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $115.65 | General |
| Category: KRYSTEXXA | ||||||
| 06/19/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: KRYSTEXXA | ||||||
| 05/14/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $101.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/04/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $113.29 | General |
| Category: KRYSTEXXA | ||||||
| 03/22/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $138.41 | General |
| Category: KRYSTEXXA | ||||||
| 11/20/2017 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | Cash or cash equivalent | $115.43 | General |
| Category: KRYSTEXXA | ||||||
| 07/05/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 931 | 1,202 | $466,421 | $83,641 |
| 2022 | 10 | 816 | 1,127 | $418,019 | $77,215 |
| 2021 | 13 | 881 | 1,233 | $359,878 | $83,267 |
| 2020 | 10 | 645 | 1,068 | $128,201 | $44,857 |
Total Patients
3,273
Total Services
4,630
Medicare Billing
$288,979
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 252 | $173,628 | $25,291 | 14.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 166 | 166 | $93,956 | $24,933 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 177 | 278 | $137,332 | $19,469 | 14.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 49 | 49 | $10,290 | $3,518 | 34.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $14,331 | $3,269 | 22.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 229 | 328 | $12,542 | $2,730 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $14,672 | $2,237 | 15.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 50 | $5,350 | $1,799 | 33.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 29 | $4,031 | $336.57 | 8.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 17 | $289.00 | $57.97 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 163 | 340 | $167,960 | $24,294 | 14.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 138 | 138 | $77,742 | $21,521 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 157 | $108,173 | $15,362 | 14.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 33 | 33 | $27,819 | $6,628 | 23.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 19 | 19 | $16,720 | $3,816 | 22.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 40 | 41 | $8,036 | $2,804 | 34.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 44 | 45 | $4,815 | $1,589 | 33.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 221 | 324 | $4,536 | $960.39 | 21.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $1,946 | $185.35 | 9.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 15 | 16 | $272.00 | $54.96 | 20.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 154 | 222 | $105,711 | $24,332 | 23.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 163 | 317 | $121,411 | $23,539 | 19.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 132 | 132 | $74,712 | $20,894 | 28.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 51 | 51 | $9,333 | $3,328 | 35.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 15 | 15 | $12,645 | $2,980 | 23.6% |
About Dr. Roger Perrone, M.D
Dr. Roger Perrone, M.D is a Internal Medicine healthcare provider based in Northport, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417905696.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Perrone, M.D has received a total of $1,748 in payments from pharmaceutical and medical device companies, with $149.12 received in 2023. These payments were reported across 21 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,736).
As a Medicare-enrolled provider, Perrone has provided services to 3,273 Medicare beneficiaries, totaling 4,630 services with total Medicare billing of $288,979. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Northport, NY
- Active Since 05/04/2006
- Last Updated 08/13/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1417905696
Products in Payments
- KRYSTEXXA (Biological) $731.47
- KRYSTEXXA (Drug) $506.99
- FARXIGA (Drug) $204.38
- APOLLO ESG System (Device) $149.12
- Repatha (Biological) $125.00
- ADVAIR (Drug) $23.05
- RAYOS (Drug) $7.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Northport
Dr. Stephen Browne, M.d, M.D
Internal Medicine — Payments: $20,215
Internal Medicine $20,215
Brittany Hill, Do, DO
Internal Medicine — Payments: $16,519
Internal Medicine $16,519
Paul Leva, Md, MD
Internal Medicine — Payments: $14,754
Internal Medicine $14,754
Ginny Leva, Md, MD
Internal Medicine — Payments: $8,840
Internal Medicine $8,840
Dr. Richard Boughal, Md, MD
Internal Medicine — Payments: $756.92
Internal Medicine $756.92
Dr. Hillary Diamond, M.d, M.D
Internal Medicine — Payments: $601.48
Internal Medicine $601.48